CaReBios is involved in the development of animal models,  mouse and zebrafish,  necessary for screening new drugs for the treatment of cancer. Through the use of engineered animal models, it is possible to study the effectiveness of the compound under investigation and characterize its mechanism of action

Most human cancers derive from the accumulation of multiple genetic defects contributing in different ways to the biological appearance and clinical characteristics of CANCERS. In the NEAR FUTURE Cancer Treatment will require novel therapeutic molecules targeting specific alterations of transformed cells.  
CAREBIOS discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases and in providing multiple oncological models to select new active drugs, either small molecules or biologics biotech.